US6024961012
US6024961012
MiMedx Group, Inc
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 418.630.000 | 348.879.000 | 20.0% |
| Cost of Revenue | 73.013.000 | 60.073.000 | 21.5% |
| Gross Profit | 345.617.000 | 288.806.000 | 19.7% |
| 281.730.000 | 229.495.000 | 22.8% | |
| Operating Income | 63.887.000 | 59.311.000 | 7.7% |
| Pretax Income | 66.262.000 | 57.294.000 | 15.7% |
| Net Income Common Stockholders | 48.578.000 | 42.419.000 | 14.5% |
| -- | -- | -- | |
| -- | -- | -- |